• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受肺静脉隔离术的心房颤动患者的生活质量:短期随访研究。

Quality of Life in Patients with Atrial Fibrillation Undergoing Pulmonary Vein Isolation: Short-Term Follow-Up Study.

机构信息

Pauls Stradins Clinical University Hospital, LV-1002 Riga, Latvia.

Faculty of Medicine, Riga Stradins University, LV-1007 Riga, Latvia.

出版信息

Medicina (Kaunas). 2024 Sep 28;60(10):1594. doi: 10.3390/medicina60101594.

DOI:10.3390/medicina60101594
PMID:39459381
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11509510/
Abstract

Atrial fibrillation (AF) significantly impacts the quality of life (QoL) of affected individuals. Pulmonary vein isolation (PVI) has emerged as a therapeutic approach to manage AF and improve QoL. This study aimed to assess the QoL in patients with AF undergoing PVI. A total of 97 AF patients undergoing PVI (radiofrequency 52.6% (n = 51) and cryoablation 47.4% (n = 46)) at Pauls Stradins Clinical University Hospital were included in this study. QoL was measured using the 36-Item Short-Form Survey (SF-36) before PVI and during a follow-up period of 5.98 ± 1.97 months. This study consisted of 60.8% (n = 59) males, with a mean age of 60.06 ± 11.61 years. A total of 67.0% (n = 65) of patients had paroxysmal AF, and 33.0% (n = 32) had persistent AF. The SF-36 questionnaire revealed major improvements across multiple QoL domains post-PVI, reaching a statistical significance of < 0.01. Patient factors, such as female gender ([estimate 21.26, 95% CI (7.18, 35.35)], < 0.01), persistent AF ([estimate 15.49, 95% CI (2.83, 28.15)], = 0.02), and restored sinus rhythm ([estimate 14.35, 95% CI (1.65, 27.06)], = 0.03), were associated with significantly improved QoL. PVI in patients with AF positively influences various dimensions of QoL, as evidenced by significant improvement across multiple SF-36 domains. These findings emphasize worsened QoL in patients with AF and the potential benefits of PVI enhancing the overall wellbeing of individuals with AF.

摘要

心房颤动(AF)显著影响受影响个体的生活质量(QoL)。肺静脉隔离(PVI)已成为管理 AF 和改善 QoL 的治疗方法。本研究旨在评估接受 PVI 的 AF 患者的 QoL。本研究共纳入了 97 例在 Pauls Stradins 临床大学医院接受 PVI(射频消融 52.6%(n=51)和冷冻消融 47.4%(n=46))的 AF 患者。在 PVI 前和随访期间 5.98±1.97 个月,使用 36 项简短健康调查问卷(SF-36)测量 QoL。本研究包括 60.8%(n=59)的男性,平均年龄为 60.06±11.61 岁。共有 67.0%(n=65)的患者患有阵发性 AF,33.0%(n=32)的患者患有持续性 AF。SF-36 问卷显示,PVI 后多个 QoL 领域有显著改善,达到统计学意义(P<0.01)。患者因素,如女性性别([估计值 21.26,95%置信区间(7.18,35.35)],P<0.01)、持续性 AF([估计值 15.49,95%置信区间(2.83,28.15)],P=0.02)和窦性节律恢复([估计值 14.35,95%置信区间(1.65,27.06)],P=0.03)与 QoL 的显著改善相关。AF 患者的 PVI 对 QoL 的多个维度产生积极影响,这体现在多个 SF-36 领域的显著改善。这些发现强调了 AF 患者 QoL 的恶化以及 PVI 增强 AF 患者整体健康的潜在益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cd/11509510/9aa3dee6f9a2/medicina-60-01594-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cd/11509510/81ffe7636c0e/medicina-60-01594-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cd/11509510/9aa3dee6f9a2/medicina-60-01594-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cd/11509510/81ffe7636c0e/medicina-60-01594-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cd/11509510/9aa3dee6f9a2/medicina-60-01594-g002.jpg

相似文献

1
Quality of Life in Patients with Atrial Fibrillation Undergoing Pulmonary Vein Isolation: Short-Term Follow-Up Study.接受肺静脉隔离术的心房颤动患者的生活质量:短期随访研究。
Medicina (Kaunas). 2024 Sep 28;60(10):1594. doi: 10.3390/medicina60101594.
2
Health-related quality of life changes in patients undergoing repeated catheter ablation for atrial fibrillation.接受反复导管消融治疗心房颤动患者的健康相关生活质量变化
Clin Res Cardiol. 2016 Jan;105(1):1-9. doi: 10.1007/s00392-015-0879-3. Epub 2015 Jun 24.
3
Relationship of quality of life with procedural success of atrial fibrillation (AF) ablation and postablation AF burden: substudy of the STAR AF randomized trial.生活质量与心房颤动(AF)消融程序成功和消融后 AF 负荷的关系:STAR AF 随机试验的亚研究。
Can J Cardiol. 2013 Oct;29(10):1211-7. doi: 10.1016/j.cjca.2013.06.006. Epub 2013 Aug 26.
4
Quality of life improvements by durable pulmonary vein isolation in patients with atrial fibrillation.持续性肺静脉隔离对房颤患者生活质量的改善。
J Cardiovasc Electrophysiol. 2020 Aug;31(8):2013-2021. doi: 10.1111/jce.14592. Epub 2020 Jun 4.
5
Cryoballoon pulmonary vein isolation versus radiofrequency ablation of the pulmonary veins and left atrial posterior wall: Patient-reported outcomes.冷冻球囊肺静脉隔离术与肺静脉和左心房后壁射频消融术比较:患者报告结局。
Pacing Clin Electrophysiol. 2024 May;47(5):595-602. doi: 10.1111/pace.14943. Epub 2024 Mar 25.
6
Quality of life and healthcare utilisation improvements after atrial fibrillation ablation.房颤消融术后生活质量和医疗保健利用率的改善。
Heart. 2021 Aug;107(16):1296-1302. doi: 10.1136/heartjnl-2020-318676. Epub 2021 May 5.
7
Pulmonary venous isolation by antral ablation with a large cryoballoon for treatment of paroxysmal and persistent atrial fibrillation: medium-term outcomes and non-randomised comparison with pulmonary venous isolation by radiofrequency ablation.使用大球囊冷冻消融进行肺静脉隔离治疗阵发性和持续性心房颤动:中期结果和与射频消融肺静脉隔离的非随机比较。
Heart. 2010 Sep;96(17):1379-84. doi: 10.1136/hrt.2009.192419.
8
Different Effects of Pulmonary Vein Isolation on Quality of Life Between Patients with Persistent and Paroxysmal Atrial Fibrillation.肺静脉隔离术对持续性与阵发性心房颤动患者生活质量的不同影响
Int Heart J. 2019 Nov 30;60(6):1328-1333. doi: 10.1536/ihj.19-201. Epub 2019 Nov 15.
9
Effect of Catheter Ablation Using Pulmonary Vein Isolation With vs Without Posterior Left Atrial Wall Isolation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The CAPLA Randomized Clinical Trial.导管消融术采用肺静脉隔离与不隔离左心房后壁对持续性心房颤动患者房性心律失常复发的影响:CAPLA 随机临床试验。
JAMA. 2023 Jan 10;329(2):127-135. doi: 10.1001/jama.2022.23722.
10
Predictive value of B-type natriuretic peptide levels in patients with paroxysmal and persistent atrial fibrillation undergoing pulmonary vein isolation.B型利钠肽水平在接受肺静脉隔离术的阵发性和持续性心房颤动患者中的预测价值
J Interv Card Electrophysiol. 2011 Apr;30(3):217-25. doi: 10.1007/s10840-010-9540-2. Epub 2011 Jan 20.

引用本文的文献

1
Impact of Ablation Energy Sources on Perceived Quality of Life and Symptom in Atrial Fibrillation Patients: A Comparative Study.消融能量来源对心房颤动患者生活质量感知及症状的影响:一项比较研究。
J Clin Med. 2025 Apr 16;14(8):2741. doi: 10.3390/jcm14082741.

本文引用的文献

1
Impact of Atrial Fibrillation Burden on Health Care Costs and Utilization.房颤负担对医疗保健成本和利用的影响。
JACC Clin Electrophysiol. 2024 Apr;10(4):718-730. doi: 10.1016/j.jacep.2023.12.011. Epub 2024 Feb 28.
2
Psychosocial factors associated with medication burden among community-dwelling older people with multimorbidity.与患有多种疾病的社区老年人药物负担相关的社会心理因素。
BMC Geriatr. 2023 Nov 14;23(1):741. doi: 10.1186/s12877-023-04444-6.
3
No Effect of Continued Antiarrhythmic Drug Treatment on Top of Optimized Pulmonary Vein Isolation in Patients With Persistent Atrial Fibrillation: Results From the POWDER-AF2 Trial.
持续性心房颤动患者在优化肺静脉隔离基础上继续抗心律失常药物治疗无效果:POWDER-AF2试验结果
Circ Arrhythm Electrophysiol. 2023 Nov;16(11):e012043. doi: 10.1161/CIRCEP.123.012043. Epub 2023 Nov 3.
4
EUropean real-world outcomes with Pulsed field ablatiOn in patients with symptomatic atRIAl fibrillation: lessons from the multi-centre EU-PORIA registry.脉冲场消融治疗有症状心房颤动患者的欧洲真实世界结局:来自多中心 EU-PORIA 注册研究的经验。
Europace. 2023 Jul 4;25(7). doi: 10.1093/europace/euad185.
5
Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial.脉冲场消融治疗心房颤动:PULSED AF 关键试验。
Circulation. 2023 May 9;147(19):1422-1432. doi: 10.1161/CIRCULATIONAHA.123.063988. Epub 2023 Mar 6.
6
Heart-Focused Anxiety, General Anxiety, Depression and Health-Related Quality of Life in Patients with Atrial Fibrillation Undergoing Pulmonary Vein Isolation.接受肺静脉隔离术的房颤患者的心脏聚焦性焦虑、广泛性焦虑、抑郁及健康相关生活质量
J Clin Med. 2022 Mar 22;11(7):1751. doi: 10.3390/jcm11071751.
7
Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation.冷冻消融或药物治疗用于初始治疗心房颤动。
N Engl J Med. 2021 Jan 28;384(4):305-315. doi: 10.1056/NEJMoa2029980. Epub 2020 Nov 16.
8
Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation.冷冻球囊消融术作为心房颤动的初始治疗。
N Engl J Med. 2021 Jan 28;384(4):316-324. doi: 10.1056/NEJMoa2029554. Epub 2020 Nov 16.
9
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.心房颤动患者的早期节律控制治疗。
N Engl J Med. 2020 Oct 1;383(14):1305-1316. doi: 10.1056/NEJMoa2019422. Epub 2020 Aug 29.
10
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动诊断和管理指南:欧洲心脏病学会(ESC)心房颤动诊断和管理特别工作组,由ESC欧洲心律协会(EHRA)特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.